<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7214343\results\search\drug\results.xml">
  <result pre="for emergency LTX. Common causes of acute liver failure include" exact="acetaminophen" post="overdose, acute viral hepatitis, drug-induced liver injury, mushroom poisoning,"/>
  <result pre="unlikely to be required. White: No clinically significant interaction expected." exact="Chloroquine" post="and hydroxychloroquine Chloroquine and hydroxychloroquine act either as viral"/>
  <result pre="be required. White: No clinically significant interaction expected. Chloroquine and" exact="hydroxychloroquine" post="Chloroquine and hydroxychloroquine act either as viral entry blockers"/>
  <result pre="required. White: No clinically significant interaction expected. Chloroquine and hydroxychloroquine" exact="Chloroquine" post="and hydroxychloroquine act either as viral entry blockers or"/>
  <result pre="No clinically significant interaction expected. Chloroquine and hydroxychloroquine Chloroquine and" exact="hydroxychloroquine" post="act either as viral entry blockers or as immunomodulators."/>
  <result pre="effects, and interactions with other medications are well known [55]." exact="Chloroquine" post="has potential interactions with commonly used drugs like ampicillin,"/>
  <result pre="used drugs like ampicillin, amlodipine, azithromycin, propranolol, and antacids [56]." exact="Chloroquine" post="has significant drug interaction with ciclosporin as it increases"/>
  <result pre="propranolol, and antacids [56]. Chloroquine has significant drug interaction with" exact="ciclosporin" post="as it increases levels of cyclosporin by decreasing its"/>
  <result pre="it increases levels of cyclosporin by decreasing its metabolism. Also," exact="Chloroquine" post="increases levels of tacrolimus by the same mechanism but"/>
  <result pre="cyclosporin by decreasing its metabolism. Also, Chloroquine increases levels of" exact="tacrolimus" post="by the same mechanism but to a lesser extent"/>
  <result pre="be affected by enzyme inducers like Clarithromycin, Rifampin, Phenytoin, and" exact="Phenobarbital" post="[57]. Favipiravir It is also an investigational drug with"/>
  <result pre="treatment of HIV infection. The cytochrome P450 inhibitory effects of" exact="ritonavir" post="prolong the half-life of Lopinavir and extend its protease"/>
  <result pre="by Lopinavir/ritonavir in liver transplant recipients [58]. Lopinavir/ritonavir can increase" exact="chloroquine" post="and hydroxychloroquine concentrations. Also, Lopinavir/ritonavir induces QT interval prolongation"/>
  <result pre="in liver transplant recipients [58]. Lopinavir/ritonavir can increase chloroquine and" exact="hydroxychloroquine" post="concentrations. Also, Lopinavir/ritonavir induces QT interval prolongation that may"/>
  <result pre="concentrations. Also, Lopinavir/ritonavir induces QT interval prolongation that may potentiate" exact="chloroquine" post="and hydroxychloroquine toxicity [57]. Tocilizumab Tocilizumab is a monoclonal"/>
  <result pre="Lopinavir/ritonavir induces QT interval prolongation that may potentiate chloroquine and" exact="hydroxychloroquine" post="toxicity [57]. Tocilizumab Tocilizumab is a monoclonal antibody that"/>
  <result pre="calcineurin inhibitors with necessary drug level monitoring. Its use with" exact="chloroquine" post="and hydroxychloroquine may have additive toxicity. Also, It may"/>
  <result pre="with necessary drug level monitoring. Its use with chloroquine and" exact="hydroxychloroquine" post="may have additive toxicity. Also, It may potentiate hematological"/>
  <result pre="have additive toxicity. Also, It may potentiate hematological toxicity of" exact="ribavirin" post="and interferon-beta if used together as Tocilizumab has a"/>
  <result pre="if used together as Tocilizumab has a myelosuppressive effect [57]." exact="Ribavirin" post="Ribavirin is an old antiviral drug used in the"/>
  <result pre="used together as Tocilizumab has a myelosuppressive effect [57]. Ribavirin" exact="Ribavirin" post="is an old antiviral drug used in the treatment"/>
  <result pre="the treatment of SARS. As it causes dose-dependent hemolytic anemia," exact="Ribavirin" post="may potentiate the hematological toxicity of Interferon-beta and Tocilizumab."/>
  <result pre="Ribavirin may potentiate the hematological toxicity of Interferon-beta and Tocilizumab." exact="Ribavirin" post="had no significant interaction with immunosuppressive drugs [57]. Interferon"/>
  <result pre="should not be combined with Tocilizumab. Also, potential interaction with" exact="chloroquine" post="and hydroxychloroquine may increase its toxicity [57]. Management of"/>
  <result pre="be combined with Tocilizumab. Also, potential interaction with chloroquine and" exact="hydroxychloroquine" post="may increase its toxicity [57]. Management of liver transplant"/>
  <result pre="dosage; consider decreasing tacrolimus/cyclosporine by 50%, stop mycophenolate (CellCept/Myfortic) and" exact="Azathioprine" post="especially in the setting of lymphopenia, fever, or worsening"/>
  <result pre="the case of ground-glass opacities, pneumonia switching mammalian target of" exact="rapamycin" post="(mTOR) to calcineurin inhibitors (CNI, e.g., tacrolimus) should be"/>
  <result pre="stop all immunosuppression [59]. For outpatients on belatacept, switching to" exact="tacrolimus" post="or cyclosporine should be considered after 28Â days from"/>
  <result pre="immunosuppression [59]. For outpatients on belatacept, switching to tacrolimus or" exact="cyclosporine" post="should be considered after 28Â days from the last"/>
  <result pre="CNI should be considered. For CNI intolerant patients, increasing daily" exact="prednisone" post="dose from 5Â mg to 7.5â€&quot;10Â mg daily might"/>
  <result pre="mg to 7.5â€&quot;10Â mg daily might be considered. Low dose" exact="prednisone" post="(5Â mg) in all patients who were receiving it"/>
 </snippets>
</snippetsTree>
